You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 3, March 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal

Nasopharyngectomy for Recurrent Nasopharyngeal Cancer

A 2- to 17-Year Follow-up

Willard E. Fee, Jr, MD; Melinda S. Moir, MD; Eun Chang Choi, MD; Don Goffinet, MD

Arch Otolaryngol Head Neck Surg. 2002;128:280-284.

Objective  To review the 2- to 17-year outcome of nasopharyngectomy following local recurrence of nasopharyngeal carcinoma.

Design  Retrospective review.

Setting  University medical center.

Patients  Thirty-seven patients with biopsy-proven recurrent nasopharyngeal cancer followed up for a minimum of 2 years after transpalatal, transmaxillary, and/or transcervical resection with and without neck dissection.

Outcome  Clinical examination, magnetic resonance imaging, chest x-ray examination, and liver function tests to determine re-recurrence; unlimited follow-up.

Results  With a mean follow-up of 5.4 years, the crude, 5-year, overall, free-of-disease survival rate was 52%, local control at 5 years was 67%, and the 5-year actuarial survival rate was 60%. Survival by recurrent T stage (rT) was as follows: rT1, 73%; rT2, 40%; rT3, 14%; and rT4, 0%. Complications occurred in 54% and included 1 death from carotid artery injury and 1 patient with permanent pharyngeal plexus paralysis with resultant dysphagia. The remaining patients had transitory complications that spontaneously resolved, required further surgery (closure of palate fistula, debridement, and reapplication of skin graft), or required further medical therapy.

Conclusions  The results of this study are better than most published reports of additional irradiation for rT1 and rT2 lesions. More recent radiation studies that use radiosurgery or implants suggest promising early results. A randomized prospective study comparing surgery with additional irradiation for recurrent disease at the primary site is warranted.


From the Division of Otolaryngology/Head and Neck Surgery (Drs Fee, Moir, and Choi) and Department of Radiation Oncology (Dr Goffinet), Stanford University, Stanford, Calif. Dr Choi is now with the Department of Otolaryngology, Yonsei University, Seoul, Korea.


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2002;128(3):332-334.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nasopharyngectomy and Surgical Margin Status: A Survival Analysis
Vlantis et al.
Arch Otolaryngol Head Neck Surg 2007;133:1296-1301.
ABSTRACT | FULL TEXT  

Curative Surgery for Recurrent Nasopharyngeal Carcinoma via the Infratemporal Fossa Approach
Choi and Lee
Arch Otolaryngol Head Neck Surg 2005;131:213-216.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.